Abstract
Bone marrow transplantation (BMT) is a promising method of treatment for children with resistant malignancies. The discrepancies in the results of BMT from institution to institution are based on patient selection, timing of transplantation, and preparatory regimens that differ from place to place. Studies that address specific questions are needed: questions like Under what conditions is BMT superior to conventional chemotherapy? Which preparatory regimen is superior? What are the results based on the status of the patients' malignancies and quality of life? Multi-institutional studies are needed to answer these questions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
